Inside NIA Archives: Alzheimer's Disease
We’re excited to be attending this meeting because it gives us here at NIA a chance to connect and re-connect with current and potential grantees. We’re hoping to see many of you at the... Read More
Our nation is focused as never before on investing resources—in time, talent, and treasure—to find effective treatments for this devastating disorder called Alzheimer’s disease (AD... Read More
Just last week, I had the honor of presenting, on behalf of NIH Director Dr. Francis Collins, the first-ever NIH Professional Judgment Budget for Alzheimer’s disease and related dementias.... Read More
We will be posting a new pay line for Alzheimer’s research, and I want to alert you to two important facts around it. First, the new pay lines are nine percentage points higher than our general... Read More
If you’re struggling to recruit enough participants for your study, you are not alone. When time, staff, and other recruitment resources are limited, this can be a tough problem. How can you... Read More
Every NIH institute has an executive responsible for managing its business organization. This is someone who keeps computer systems, buildings, human resources, contracts, and budget operations... Read More
We’re excited about participating in the upcoming annual meeting of the American Geriatrics Society, May 14–17 at National Harbor, just outside of Washington, DC. And, we’re hoping... Read More
We posted an update to our funding policy on Friday. The sobering news is that for most areas of research within NIA’s mission the payline will be at the 8th percentile, with 5th percentile for... Read More
The explosion of Big Data promises to transform biomedical research, but all too often researchers are stymied by limited access to these complex biomedical data sets. To overcome some of these... Read More
Last year (fiscal year 2014), we received $100 million of additional appropriated funds largely to support research on Alzheimer’s disease. We allocated those funds using mechanisms including... Read More
Identifying the genes involved in Alzheimer’s disease and related dementias is of course no easy task. From among the thousands of gene candidates in the human genome, we need to determine... Read More
Every week, the NIA blog brings you important information on funding, grants, scientific resources, and other topics of interest to researchers. Have a question you’d like us to cover? Let us... Read More
Determining the best way forward in Alzheimer’s disease research is as challenging and complicated as the disorder itself.
My dedicated staff in the Division of Neuroscience oversees and... Read More
Are you studying the genetics of late-onset Alzheimer’s disease? Did you know that the Alzheimer’s disease research community has a database that gives you access to a broad range of... Read More
International collaboration is vital to advancing Alzheimer’s disease research on multiple fronts, from genetics to biomarkers to translational research.
Just weeks ago, at the Alzheimer’... Read More
Do you struggle to recruit older participants into your research? Researchers tell us that recruiting older adults—especially from underrepresented groups—is challenging, while the need... Read More
With apologies to Dickens and to Chaplin…
It is the best of times.
When the dust cleared on our budget this year, the NIA was blessed with a 12.5%, $130 million increase over fiscal year... Read More
Last month, the NIA got good news about our budget for fiscal year 2014: $130 million more than last year. We are grateful for this increase. It means that this year there will be more funding than... Read More
Optimism and pessimism compete with each other as we contemplate the future for research and research funding. The prospects for important breakthroughs in NIA’s primary areas of medical... Read More
Did you know that there’s a new way to search for funded research projects in Alzheimer’s disease?
You can find out who is doing work in your area of interest in the US and other... Read More
It was the best of times, it was the worst of times... --Charles Dickens
These words sum up the state of Alzheimer’s disease (AD) research, specifically therapy development, over the last few... Read More